IRCT20211017052794N1尚未招募3 期
Evaluation of the effect of adding Trimetazidine to standard treatment of patients with Aluminum phosphide poisoning,referal to Loghman Hospital In Tehran? a pilot study on mortality
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years(—)
- 性别
- All
入选标准
- •Consumption of oral form of Aluminium phosphide and referrs to Loghman Hospital under 24 hours and the presence of symptoms consistent with poisoning
- •Positive silver nitrate test
- •Carbon monoxide levels above 10 in non-smokers
排除标准
- •Glomerular Filtration Rate(GFR) less than 30 (if available ),history of renal failure , history of liver failure , history of acute myocardial infarction, history of heart failure, history of congenital heart disease
- •Pregnancy and lactation
- •Refer to hospital after 24 hours
研究者
相似试验
已完成
4 期
Effect of Trimetazidine on clinical events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.Ischemic heart diseaseST-elevation myocardial infarctionCardiovascular - Coronary heart diseaseACTRN12619001616167Hamlet Hayrapetyan, FESC680
进行中(未招募)
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.Patients with Angina pectoris having been treated by Percutaneous Coronary InterventionMedDRA version: 16.1Level: PTClassification code 10002383Term: Angina pectorisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-022134-89-GRI.R.I.S.10,300
进行中(未招募)
1 期
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-LVI.R.I.S.10,300
撤回
3 期
The efficAcy and safety of Trimetazidine in Patients with angina pectoris having been treated by percutaneous Coronary Intervention. ATPCI study An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.chest painspasm of the heart10011082NL-OMON38975Servier200
进行中(未招募)
不适用
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.EUCTR2010-022134-89-EEI.R.I.S.10,300
